6 March 2017 - A stakeholder forum will be held for the post-market review of chronic obstructive pulmonary disorder medicines on 21 March 2017 in Sydney.
Pharmaceutical sponsors of COPD medicines listed on the PBS, representatives of peak bodies, consumer organisations, and individuals who provided a submission to the Review have been invited to participate.
Attendance is by invitation only.